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Introduction
Evidence of cognitive deficits including altered acquisition of new 
motor skills, paired attention, planning, and memory has been 
demonstrated in Huntington’s disease (HD) patients before the 
onset of motor symptoms (1–3). These clinical signs have been 
mainly attributed to corticostriatal dysfunction (4, 5). However, 
in recent years the idea has emerged that memory decline in HD 
is likely a reflection of a widespread brain circuitry defect and 
not exclusively a dysfunction of the basal ganglia (6–8). Indeed, 
besides the caudate and putamen, the volume of the hippocampus 
is reduced in premanifest HD individuals, while no changes in the 
amygdala, thalamus, or pallidum are observed (9). Interestingly, 
spatial and recognition memories have been reported to be altered 
in HD patients. Thus, in moderately advanced HD patients there 
is a simultaneous impairment of allocentric (hippocampal-depen-
dent) and egocentric (striatal-dependent) spatial navigation, sup-
porting the idea that beyond the atrophy of the striatum and cor-
tex, a more general neurodegenerative process that involves the 
hippocampus could contribute to HD memory impairment (2, 10, 
11). Actually, cytoplasmic and nuclear huntingtin aggregates with-
in the hippocampus have been described in HD individuals (12). 
Importantly, such behavioral deficits, together with hippocampal 
long-term potentiation (LTP) disturbances, have been replicated 
in different HD mouse models (2, 13–15). Although altered synap-
tic plasticity and aberrant dendritic spine density and morphology 
have been proposed as underlying mechanisms (14, 16, 17), little is 
known about the precise molecular pathways involved in HD syn-
aptic and memory disturbances.
In the adult brain, neurotrophins play a critical role in syn-
aptic plasticity regulation. Among the different neurotrophins, 
brain-derived neurotrophic factor (BDNF) is the best character-
ized for its role in regulating LTP and long-term depression (LTD) 
through binding to TrkB and p75NTR receptors (18). It is generally 
accepted that BDNF via interaction with TrkB receptors modu-
lates synaptic transmission and plasticity in adult synapses by 
regulating transcription, translation, and trafficking of distinct 
synaptic proteins (19, 20). Less is known about the role of p75NTR 
in synaptic plasticity. Null p75NTR mice show improved spatial 
learning and enhanced LTP (21, 22) while impaired NMDA-
dependent LTD (23), which points to an antagonistic role of 
p75NTR in synaptic plasticity. Moreover, it has been demonstrated 
that p75NTR is a negative modulator of spine-dendrite morphol-
ogy and complexity (24), likely by regulation of RhoA activity 
(25). Consistently, while p75NTR–/– mice exhibit increased hippo-
campal dendritic spine density, overexpression of p75NTR in hip-
pocampal neurons decreases spine number and branching (24). 
Interestingly, upregulation of p75NTR levels has been reported in 
the cortex and hippocampus of Alzheimer’s disease (AD) patients 
(26), while small-molecule p75NTR ligands prevent both cognitive 
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Results
Increased p75NTR expression in the hippocampus of HD mouse mod-
els and HD patients. Previous data from our group demonstrated 
increased levels of p75NTR in the striatum of HD mice as well as 
in the putamen of HD patients (30). To analyze the role of p75NTR 
in HD memory dysfunction, we extended these data by evaluat-
ing hippocampal and cortical p75NTR levels in 2 HD mouse models 
at different stages and in postmortem human HD samples. The 2 
different HD mouse models, R6/1 and HdhQ7/Q111 knock-in mutant 
mice (mutant KI mice), differ in the onset and progression of HD 
phenotypes; R6/1 mice show earlier onset and faster disease pro-
gression than mutant KI mice (31). Quantitative Western blot anal-
ysis revealed a significant increase in hippocampal p75NTR levels in 
HD mutant mice at early disease stages (2 months and 4 months 
in R6/1 and KI mice, respectively), levels that remained elevated 
at late stages (Figure 1, A and C). Interestingly, cortical p75NTR lev-
els were similar between genotypes (Figure 1, B and D). To ana-
lyze whether deregulation of p75NTR levels also occurs in humans, 
we examined hippocampal and cortical tissue from controls and 
decline and neuritic dystrophy in AD mouse models (27–29). In 
this scenario, we were interested to explore whether p75NTR plays 
a role in different memory deficits in HD. To this aim we have 
examined the levels of p75NTR in the hippocampus of 2 distinct 
HD mouse models, exon 1 and full-length, as well as in the hippo-
campus of HD patients. p75NTR levels were increased at early HD 
disease stages in the hippocampus of HD mice and also in post-
mortem samples from HD patients. Increased p75NTR levels were 
accompanied by long-term memory deficits, altered LTP, reduced 
levels of synaptic proteins, decreased dendritic spine density, and 
hyperactivation of the small GTPase RhoA. Such alterations were 
mimicked by overexpression of p75NTR in WT mice and reversed 
by genetic normalization of p75NTR levels in HD mutant mice. 
Finally, specific reduction of p75NTR in the hippocampus of HD 
mice by intracranial injections of AAV-shp75NTR prevented HD 
memory impairments. In summary, our findings identify p75NTR 
as a crucial mediator of synapse loss and cognitive decline in HD 
and provide mechanistic rationale for p75NTR as a novel target to 
treat memory deficits in HD.
Figure 1. p75NTR expression is 
increased in the hippocampus 
but not in the cortex of 2 dif-
ferent HD mouse models and in 
HD human brain. (A–D) Western 
blot for p75NTR and actin as load-
ing control in total hippocampus 
and cortex extracts from WT and 
KI mice (A and B) or WT and R6/1 
mice (C and D) at different ages 
(n = 5–7 per genotype). Right: 
Representative immunoblots. 
At 8 and 7 months, lanes were 
run on the same gel but were 
noncontiguous (white line). (E 
and F) Western blot for p75NTR 
and actin as a loading control in 
total hippocampus and cortex 
extracts from control and HD 
brain samples (n = 6–7). Right: 
Representative immunoblots. 
All plots represent mean ± SEM. 
Student’s 2-tailed t test was 
performed. *P < 0.05, **P < 0.01  
compared with WT mice or 
control human samples.
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Altered p75NTR synaptic location in HdhQ7/Q111 knock-in mutant 
mice. Mutant KI and R6/1 mice develop age-dependent memory 
deficits (13, 15). Given the role of p75NTR in synaptic plasticity (19, 
24, 35), we next analyzed whether the increase in p75NTR levels 
in the hippocampus of mutant KI mice could be involved in HD 
memory deficits. To address this question, levels of p75NTR were 
normalized in KI mice by cross-mating of HdhQ7/Q111 mice with 
p75NTR/ExonIII+/– mice (p75+/– mice) to obtain double-mutant mice 
(KI:p75+/– mice). Hippocampal extracts from WT, mutant KI, het-
erozygous p75+/–, and double-mutant KI:p75+/– mice were analyzed 
by Western blot. As expected, quantification of band intensities 
revealed a significant increase of p75NTR in mutant KI mice, an 
increase that was reversed in double-mutant KI:p75+/– mice (Figure 
3A). Confocal analysis of brain sections showed p75NTR immunore-
activity as a punctate staining in pyramidal cell bodies as well as in 
fibers concentrated in the stratum radiatum and more dispersed in 
the stratum oriens within the CA1 region of the hippocampus. Simi-
lar staining was observed in CA3 and the dentate gyrus (data not 
shown). According with our biochemical data, p75NTR immunoreac-
tivity in mutant KI mice was higher than in WT animals, whereas no 
significant differences were detected between double KI:p75+/– and 
WT mice (Figure 3B). When subcellular localization was analyzed 
in the CA1 region, we found that in all analyzed genotypes p75NTR 
immunoreactivity colocalized with MAP2, a dendritic marker, 
individuals affected by HD. Consistent with our data in HD mice, 
levels of p75NTR were found increased in the hippocampus but not 
in the cortex of HD patients compared with controls (hippocam-
pus: control, 100.1 ± 12.68; HD, 162.4 ± 21.69; cortex: control, 
100.02 ± 17.14; HD, 124.3 ± 22.7; Figure 1, E and F, respectively), 
which supports a pathological role for p75NTR in HD. The increase 
in hippocampal p75NTR protein levels was likely due to increased 
p75NTR transcription, since higher mRNA levels measured by RT-
PCR were found in the hippocampus but not in the cortex of HD 
versus WT mice (Figure 2, A and B). We next aimed to determine 
the molecular mechanism by which mutant huntingtin induces 
aberrant hippocampal p75NTR expression. The transcription factor 
Sp1 has been described to drive expression of p75NTR under cellu-
lar stress conditions (32, 33), while upregulation of Sp1 has been 
described in cellular and mouse models of HD (34). These data 
prompted us to investigate whether increased p75NTR expression 
was related to higher hippocampal Sp1 levels. Thus, Sp1 levels 
were determined by Western blot analysis in nuclear and cyto-
solic enriched fractions obtained from R6/1 and HD human hip-
pocampus (Figure 2, C and D). Interestingly, we found a signifi-
cant increase in Sp1 levels in the nuclear fraction in R6/1 and HD 
human hippocampus compared with WT mice and control human 
samples, suggesting that deregulated Sp1 expression could con-
tribute to aberrant expression of p75NTR in the HD hippocampus.
Figure 2. Increased hippocampal p75NTR 
mRNA expression associates with high-
er levels of Sp1 in the mouse and human 
HD hippocampus. (A and B) Histograms 
showing p75NTR mRNA expression ana-
lyzed by RT-PCR in the hippocampus (A) 
and cortex (B) of 8-month-old WT and KI 
mice and 12-week-old WT and R6/1 mice. 
Results were normalized to 18S gene 
expression. Data represent mean ± SEM 
and are expressed as fold change.  
(n = 5–8 for each genotype.) (C and D) 
Western blot for Sp1 in nuclear and 
cytosolic enriched fractions from the 
hippocampus of WT and R6/1 mice at 
14 weeks of age and from control and 
HD patients (n = 4–6). Representative 
immunoblots showing Sp1 protein levels 
in cytosolic (loading control α-tubulin) 
and nuclear (loading control NeuN) frac-
tions. Data were analyzed by Student’s 
2-tailed t test. *P < 0.05, **P < 0.01, and 
***P < 0.001 compared with WT mice or 
control human samples.
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positive for p75NTR, in mutant KI mice this percentage rose to 40%, 
suggesting that the increase in p75NTR in mutant KI mice is localized 
in spines. Importantly, this increase was completely reversed in 
double-mutant mice. Since p75NTR is also expressed by astrocytes, 
especially after neuronal damage (36, 37), coimmunostaining with 
the astrocytic marker GFAP was performed in hippocampal slices 
from WT and mutant KI mice (see Supplemental Figure 6; supple-
suggesting that p75NTR is expressed by hippocampal neurons. To 
further analyze the distribution of p75NTR, double immunostaining 
using p75NTR and PSD95 as a glutamatergic postsynaptic marker 
was conducted. We found that in apical dendrites of the CA1 region 
p75NTR staining colocalized with PSD95 immunoreactivity, reveal-
ing a postsynaptic distribution of p75NTR (Figure 3C). Interestingly, 
whereas in WT mice about 20% of PSD95-positive clusters were 
Figure 3. Increased postsynaptic localization of p75NTR in mutant KI mice. (A) Western blot for p75NTR and actin as loading control in total hippocampus 
extracts from WT, p75+/–, mutant KI, and double-mutant KI:p75+/– mice at 6 months of age (n = 6–7 per genotype) showing normalization of p75NTR levels 
in double-mutant mice. Right: Representative immunoblots. (B) Representative confocal microscopy images (low magnification) showing the expression 
pattern of p75NTR in 8-month-old mouse hippocampus. Magnified images (right) show colocalization between p75NTR and MAP2 in the CA1 hippocampal 
region. (C) Representative confocal microscopy images (high magnification) showing p75NTR and PSD95 colocalization in the CA1 hippocampal region. 
Quantitative analysis reveals a significant increase in the percentage of PSD95-positive clusters also positive for p75NTR in KI mice. Data are presented 
as mean ± SEM. One-way ANOVA with Tukey post hoc comparisons was performed; **P < 0.01 and ***P < 0.001 compared with WT mice, §§§P < 0.001 
compared with KI mice.
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In the elevated plus maze paradigm 
(Supplemental Figure 1A), all geno-
types displayed similar exploratory 
activity measured as the time in the 
open arms and the distance traveled, 
suggesting that neither KI, p75+/–, nor 
KI:p75+/– mice exhibit higher anxiety 
levels compared with WT mice. As a 
second test for anxiety-like behaviors 
we performed the light-dark box test 
(Supplemental Figure 1B). Consistent 
with our previous data, we found that 
all mice, independently of their geno-
type, made similar transitions to the 
light compartment and spent similar 
time in the light. We conclude from 
these data that nonprominent anxi-
ety-like behaviors are manifested by 
any of the genotypes studied. Then, 
spatial, recognition, and associative 
memories were analyzed (Figure 4). 
Spatial memory was evaluated by the 
T-maze spontaneous alternation task 
(T-SAT) and the object location task 
(OLT) (40, 41), both behavioral tasks 
sensitive to hippocampal dysfunc-
tion albeit not completely dependent 
(42–44). In the T-SAT test, mice have 
the natural tendency to alternate and 
enter the previously unvisited arm 
(novel arm) in a T-maze apparatus. 
At 6 months of age, mutant KI mice 
showed no preference for the novel 
versus the old arm, while a significant 
preference was observed in WT, p75+/–, 
and double-mutant KI:p75+/– mice 
(Figure 4A). In the OLT, all mice were 
first habituated to the open field arena 
and ambient conditions and then subjected to a training session 
in the presence of 2 similar objects (A1 and A2). All mice similarly 
explored both objects, indicating no object or place preferences 
between genotypes (Supplemental Figure 1C). This test is based 
on the ability of rodents to recognize when a familiar object has 
been relocated. When spatial memory was assessed 24 hours after 
training, KI mice exhibited a significantly lower preference for the 
object displaced to the new location compared with WT, p75+/–, or 
double-mutant KI:p75+/– mice (Figure 4B). Overall, these results 
indicate that normalization of p75NTR levels in KI mice rescue spa-
tial memory deficits. Similar results were obtained at 8 months of 
age in the T-SAT test, suggesting that reduced p75NTR expression in 
HD mice prevented, rather than merely delayed, spatial memory 
deficits (Supplemental Figure 2A). We next evaluated recognition 
memory by using the novel object recognition test (NORT), based 
on the natural tendency of mice to spend more time exploring a 
novel object than a familiar one and known to be dependent on 
hippocampal and cortical circuits (45–47). No significant differ-
ences between genotypes were found during the training period, 
mental material available online with this article; doi:10.1172/
JCI74809DS1). Lack of colocalization between p75NTR and GFAP 
was found, indicating that astrocytes in WT and KI mutant mice 
do not overexpress p75NTR. These findings together with our data 
showing increased p75NTR staining in KI hippocampus colocalizing 
with MAP2 suggest that neuronal p75NTR upregulation underlies 
hippocampal HD dysfunction.
Genetic normalization of p75NTR levels rescues spatial, recogni-
tion, and associative memory deficits in HdhQ7/Q111 knock-in mutant 
mice. We next assessed whether aberrant hippocampal p75NTR 
expression was associated with HD memory impairments. Spatial, 
recognition, and associative memories were evaluated in double-
mutant KI:p75+/– mice at 6 and 8 months of age, since previous 
results from our lab demonstrated lack of recognition memory 
deficits in mutant KI mice at 4 months of age (15). First, animals 
were tested in the elevated plus maze and the light-dark explora-
tion paradigms to assess anxiety-related behaviors. These tests 
are based on the natural aversion of rodents to elevated open 
spaces and brightly illuminated spaces, respectively (38, 39). 
Figure 4. Normalization of p75NTR levels in mutant KI mice rescues spatial and nonspatial memory 
deficits. (A) Percentage of time spent in arms (old versus novel) from WT, p75+/–, KI, and KI:p75+/– mice at 
6 months of age (n = 8–12 per genotype). Mutant KI mice exhibit no preference for a previously unexposed 
(novel) arm of a T-maze. (B) Percentage of nose pokes to the displaced object from WT, p75+/–, KI, and 
KI:p75+/– mice at 6 months of age. Mutant KI mice showed significantly less preference for the novel-object 
location (n = 7–8 per genotype). (C) Percentage of nose pokes to the new object from WT, p75+/–, KI, and 
KI:p75+/– mice at 6 months of age (n = 8–12 per genotype) in the novel object recognition task. Mutant KI 
mice display no preference for the novel object. (D) Latency to step-through from light to dark compart-
ment from WT, p75+/–, KI, and KI:p75+/– mice at 6 months of age (n = 8–12 per genotype). Mutant KI mice 
present worse (shorter latency to crossover) retention performance than the other genotypes. One-way 
ANOVA with Bonferroni post hoc comparisons; *P < 0.05, **P < 0.01, and ***P < 0.001 compared with WT 
mice; §P < 0.05, §§P < 0.01, and §§§P < 0.001 compared with KI mice. #P < 0.05, ##P < 0.01, and ###P < 0.001 
compared with old arm or latency to step-through in the training. Data are presented as mean ± SEM.
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indicating no object preference (Supplemental Figure 1D). Twen-
ty-four hours after training, mutant KI mice at either 6 months 
(Figure 4C) or 8 months of age (Supplemental Figure 2B) exhib-
ited a significantly lower preference for the novel object compared 
with WT, p75+/–, and double-mutant KI:p75+/– mice, indicating 
preserved long-term recognition memory in double but not in 
mutant KI mice. Finally, we examined associative memory in the 
passive avoidance task, based on the association formed between 
an aversive stimulus (electrical foot shock) and a specific environ-
mental context (light-dark) (Figure 4D), which relies on cortical 
and hippocampal circuits (48–50). Latency to step-through during 
the training session was found to be similar between genotypes. 
However, in the testing session, although all genotypes showed a 
significant increase in the latencies to enter the dark compartment 
24 hours after receiving an electrical shock, the time latency in 
mutant KI and p75+/– mice was lower than in WT or double-mutant 
KI:p75+/– mice, indicating that altered levels of p75NTR contribute to 
associative memory impairments. Altogether, these results dem-
onstrate memory decline in mutant KI mice that was prevented by 
normalization of p75NTR levels.
Figure 5. Normalization of p75NTR levels in mutant KI mice prevents functional and structural synaptic plasticity deficits. (A) Time course of fEPSP 
potentiation during HSF-induced LTP in WT (n = 3), p75+/– (n = 4), KI (n = 9), and KI:p75+/– (n = 8) mice at 6 months of age. **P < 0.01 compared with WT 
mice. (B and C) Representative basal (B) and apical dendrites (C) of CA1 pyramidal neurons from WT, p75+/–, KI, and KI:p75+/– mice at 8 months of age. 
Right: Quantitative analysis showing dendritic spine density per micrometer of dendritic length. Mutant KI mice exhibit a significant reduction in dendritic 
spines that was significantly ameliorated in double-mutant mice. One-way ANOVA with Tukey post hoc comparisons was performed (63–83 dendrites;  
n = 4–5 animals per genotype); ***P < 0.001 compared with WT mice; §§P < 0.01, §§§P < 0.001 compared with KI mice. (D) Percentage of each morphological 
type of dendritic spine (see Methods and Supplemental Figure 4 for classification criteria) from WT, p75+/–, KI, and KI:p75+/– basal dendrites at 8 months 
of age. One-way ANOVA with Tukey post hoc comparisons was performed (480 spines from 100 dendrites from 4 animals per genotype were analyzed); 
***P < 0.001 compared with WT mice. (E and F) Spine neck length distribution was examined by plotting of the cumulative frequency of neck length of all 
examined spines and comparison of distributions using the Kolmogorov-Smirnov test. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with WT mice.  
§§P < 0.01 compared with KI mice.
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Genetic normalization of p75NTR levels rescues hippocampal syn-
aptic dysfunction in HdhQ7/Q111 knock-in mutant mice. Defective 
LTP and altered dendritic spine dynamics and morphology are 
involved in early cognitive and memory deficits in HD (14, 16, 51). 
Because normalization of p75NTR levels prevented memory impair-
ments in mutant KI mice, we next examined whether this improve-
ment was accompanied by LTP recovery and/or amelioration of 
dendritic spine loss. High-frequency conditioning tetanus (HFS) 
to induce LTP was used to investigate synaptic plasticity in CA1 
hippocampal slices at 6 months of age. Baseline responses were 
monitored for 10–30 minutes before conditioning and were found 
to be stable. Mutant KI mice showed diminished HFS-induced 
LTP compared with WT animals (Figure 5A). Thus, at 60 minutes 
after tetanus, potentiation (as mean percentage of baseline) in WT 
mice was 154.3% ± 9% (n = 8 slices, 3 mice) versus 124.9% ± 5.2% 
in mutant KI mice (P < 0.01, n = 20 slices, 9 mice). By contrast, 
tetanic stimulation induced in either double-mutant KI:p75+/– 
mice or p75+/– mice led to sustained LTP (KI:p75+/–: 154.9% ± 8%, 
P < 0.01, n = 14 slices, 8 mice; p75+/–: 159.02% ± 10%, P < 0.01, 
n = 9 slices, 4 mice), which indicates that normalization of p75NTR 
levels in mutant KI mice restored the LTP impairment.
Next, hippocampal histology and spine density were exam-
ined. Stereological estimation of hippocampal volume and CA1 
pyramidal cell density revealed no significant differences between 
genotypes at 8 months of age (Supplemental Figure 3), suggesting 
no gross anatomical deficiencies in KI or KI:p75+/– mice. To com-
pare spine density and morphology, DiOlistic labeling in fixed 
brain slices was used and apical and basal dendritic spines of CA1 
pyramidal neurons were counted. Mutant KI mice displayed a sig-
nificant decrease (~20%) in basal and apical dendritic spine den-
sity compared with WT mice (Figure 5, B and C). Normalization of 
p75NTR levels completely (apical dendrites) or partially (basal den-
drites) prevented the decay in spine density in mutant KI mice, sug-
gesting that aberrant p75NTR expression in HD could contribute to 
loss of dendritic spines. To elucidate whether increased p75NTR lev-
els also affect spine morphology, dendritic spine type was assessed 
on basal dendrites of CA1 pyramidal neurons (Figure 5D). Spines 
were defined as thin, stubby, or mushroom on the basis of mor-
phology described by Harris and Stevens (ref. 52 and Supplemen-
tal Figure 4). Mutant KI mice exhibited altered spine distribution 
with a significant decrease (~20%) in the proportion of thin spines. 
Surprisingly, both p75+/– and double-mutant KI:p75+/– mice also 
presented less thin spines compared with WT mice (~20%). How-
ever, in these 2 genotypes the proportion of mushroom spines was 
significantly higher (~15%–20%), which may indicate a compensa-
tory mechanism. Finally, we assessed the spine neck length, which 
is known to influence Ca2+-dependent signaling and synaptic plas-
ticity (53). These data were plotted as cumulative distribution for 
each animal to examine in detail the potential differences (Figure 5, 
E and F). Cumulative probability indicates that either increased 
or decreased levels of p75NTR alter spine neck morphology. Thus, 
while in mutant KI mice both thin and mushroom spines exhibited 
shorter necks, in p75+/– mice the neck lengths were longer. By con-
trast, equal graph distributions were found between WT and dou-
ble-mutant KI:p75+/– mice, indicating that both genotypes display 
spines with similar neck lengths (Figure 5, E and F). Altogether, 
these data imply that HD mutant mice exhibited not only reduced 
dendritic spine density but also a shift in the spine distribution and 
morphology. Remarkably, these dendritic changes were signifi-
cantly improved by reduction of aberrant p75NTR levels.
Deregulation of synaptic-related proteins in KI mutant mice is 
also reversed by genetic normalization of p75NTR levels. Decreased lev-
els of synaptic-related proteins have been associated with memory 
impairments and aberrant synaptic plasticity in HD (15, 16, 54, 
55). Thus, we next analyzed several synaptic markers and proteins 
involved in hippocampal synaptic plasticity in the hippocampus of 
mutant KI mice. Similar levels of the presynaptic marker synapto-
physin and the postsynaptic markers GluN1 and GluN2B (NMDA 
receptor subunits) and GluA1 and GluA2/3 (AMPA receptor sub-
units) were found between genotypes (Supplemental Table 1). 
However, levels of phospho-CaMKIIThr286, a key modulator of hip-
pocampal activity through phosphorylation of NMDA and AMPA 
receptors (56), were significantly reduced in KI mice, a reduction 
Figure 6. Normalization of p75NTR levels in mutant KI mice reverses the 
altered expression of synaptic-related proteins. Representative Western 
blots showing (A) total and phospho-CaMKIIThr286, (B) total and phospho- 
GluA1Ser831, (C) BDNF, and (D) CBP and actin as loading control in total hippo-
campus extracts from WT, p75+/–, KI, and KI:p75+/– mice at 6 months of age  
(n = 6–7 per genotype). All histograms represent mean ± SEM. One-way 
ANOVA with Tukey post hoc comparisons was performed. *P < 0.05 
compared with WT mice; §P < 0.05 and §§P < 0.01 compared with KI mice. 
pCaMKIIThr286, phospho–Ca2+/calmodulin-dependent protein kinase II at 
threonine 286; pGluA1Ser831, phospho–α-amino-3-hydroxy-5-methyl-4-
isoxazole-propionic acid receptor subunit 1 at serine 831; BDNF, brain-derived 
neurotrophic factor; CBP, CREB-binding protein.
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However, these improvements could be related to the normaliza-
tion of p75NTR levels in other brain regions known to be affected in 
HD, such as the striatum, in which p75NTR levels have been dem-
onstrated to be increased (30, 57). Therefore, we next analyzed 
whether striatal normalization of p75NTR levels in KI mutant mice 
(Figure 7A) could also ameliorate striatal-dependent behavior, 
synaptic deficits, and striatal neuropathology. To this aim, motor 
learning, corticostriatal synaptic transmission, and DARPP-32 
expression were analyzed (Figure 7). Compared with WT mice, KI 
mutant mice at 6 months of age displayed motor learning deficits 
as evidenced by decreased latency to fall during the accelerating 
rotarod test (Figure 7B). Importantly, impaired performance in 
the accelerating rotarod was not prevented or ameliorated by nor-
malization of p75NTR levels in KI:p75+/– mice. Consistent with these 
findings, when corticostriatal synaptic plasticity was analyzed by 
induction of LTP through HFS, both KI and KI:p75+/– mice displayed 
impaired LTP induction and maintenance (Figure 7C). Finally, the 
levels of the adult striatal neuronal marker DARPP-32, known to 
be reduced in HD mice from early stages (58), were determined 
by Western blot analysis in total striatal extracts obtained from 
WT, p75+/–, KI, and KI:p75+/– mice (Figure 7D). Interestingly, nor-
malization of p75NTR levels rescued reduction of striatal DARPP-32 
that was prevented by normalization of p75NTR levels in double 
KI:p75+/– mice (Figure 6A). Consistent with these data, the levels of 
the CaMKII-mediated GluA1Ser831 phosphorylation were decreased 
in KI mice, while no significant differences were found in double-
mutant mice (Figure 6B). Interestingly, the levels of 2 glutamater-
gic-scaffolding proteins such as PSD95 and SAP102 were found 
significantly increased in double KI:p75+/– mice compared with 
WT mice (Supplemental Table 1), which could be related to the 
increase in mushroom spines previously shown in these mice (Fig-
ure 4D). Finally, levels of BDNF and CREB-binding protein (CBP), 
previously found to be downregulated in the HD hippocampus 
(15, 54), were tested. As expected, levels of BDNF and CBP were 
decreased in the hippocampus of mutant KI mice, whereas no sig-
nificant differences were found when double KI:p75+/– mice were 
analyzed (Figure 6, C and D). Thus, altogether these findings sug-
gest that disruption of LTP and memory deficits in KI mutant mice 
involve deregulation of synaptic-related proteins and that normal-
ization of p75NTR levels prevents such alterations.
Genetic normalization of p75NTR levels partially restores striatal 
pathology in HdhQ7/Q111 knock-in mutant mice. Our data demonstrate 
that downregulation of p75NTR levels in KI mutant mice fully pre-
vented synaptic and cognitive deficits exhibited by these mice. 
Figure 7. Normalization of p75NTR levels in mutant KI mice slightly restores striatal pathology. (A) Western blot for p75NTR and actin as loading control in 
total striatal extracts from WT, p75+/–, mutant KI, and double mutant KI:p75+/–. (B) Latency to fall in the accelerating rotarod task procedure in WT, p75+/–, KI, 
and KI:p75+/– mice at 6 months of age. Data represent the mean ± SEM (n = 9–14 per genotype). Statistical analysis was performed using 2-way ANOVA with 
repeated measures. *P < 0.05 and **P < 0.01 compared with WT; §§P < 0.05 compared with KI. (C) Time course of fEPSP potentiation during HSF-induced LTP 
in WT (n = 7), p75+/– (n = 8), KI (n = 8), and KI:p75+/– (n = 9) mice at 4 months of age. For each slice, data were normalized to the average slope recorded during 
baseline. Data represent the mean ± SEM. Statistical differences, compared with pre-tetanus baseline amplitude values, were established using Student’s 
2-tailed t test. ***P < 0.001. (D) Western blot for DARPP-32 and actin as loading control in total striatal extracts from WT, p75+/–, KI, and KI:p75+/– mice at  
6 months of age (n = 6 per genotype). Right: Representative immunoblots. Plot represents mean ± SEM. Student’s 2-tailed t test was performed; *P < 0.05.
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ily infect neuronal cells within the 
hippocampus. First, we confirmed 
by Western blot analysis higher 
p75NTR expression in the hippocam-
pus of AAV-p75 mice compared 
with AAV-GFP (AAV-ctl) animals 
(Figure 8A). When memory func-
tion was evaluated, WT mice over-
expressing p75NTR showed impaired 
spatial and nonspatial long-term 
memories manifested as reduced 
preference for either the novel arm 
or the novel object in the T-SAT 
and NORT paradigms, respec-
tively (Figure 8, B and C) and by a 
significant retention deficit in the 
passive avoidance task (Figure 8D). 
These experiments demonstrate 
that overexpression of p75NTR in the 
WT hippocampus reproduces HD-
like memory deficits and support 
an important role for p75NTR in HD 
cognitive dysfunction.
Knockdown of p75NTR expression 
in the hippocampus of KI mice prevents 
spatial, object recognition, and asso-
ciative memories. Since hippocam-
pal p75NTR overexpression mirrored 
HD memory impairments, we next 
tested whether the specific reduc-
tion of p75NTR in the hippocampus 
of KI mice was sufficient to improve 
such memory deficits. To this aim, 
adenoviruses expressing shRNAp75 
(AAV-shp75) were infused bilater-
ally in the dorsal hippocampus of 
KI mice at 4 months of age, and 
1 month later mice were assessed by means of spatial, recognition, 
and associative memories (Figure 9). First, we tested the efficiency 
of shRNAp75 in knocking down p75NTR by testing p75NTR hippocam-
pal levels. Western blot analysis revealed a significant decrease of 
30% in p75NTR levels in KI mice infused with AAV-shp75 compared 
with those infused with AAV-ctl (Figure 9A). Then, memory func-
tion was assessed. Importantly, reduction of hippocampal p75NTR 
levels in KI mice to levels of WT completely reversed spatial, recog-
nition, and associative memory deficits (Figure 9, B–E), suggesting 
that increased expression of p75NTR in the hippocampus of HD mice 
is a key contributor of cognitive dysfunction in HD.
Increased RhoA activity contributes to loss of dendritic spines 
in KI mutant mice. The small GTPase RhoA functions as a nega-
tive modulator of dendritic spine formation and maintenance 
(59, 60), and RhoA activity is modulated by p75NTR signaling (25). 
Therefore, we hypothesized that aberrant p75NTR expression could 
contribute to synaptic and memory dysfunction in HD by alter-
ing RhoA activity and therefore affecting dendritic spine density. 
First, we tested RhoA activity in hippocampal extracts from WT, 
p75+/–, KI, and KI:p75+/– mice by pull-down analysis. Consistent 
expression in KI mice, suggesting that striatal neuronal dysfunc-
tion could be slightly ameliorated but not prevented by downregu-
lation of aberrant p75NTR expression in KI mutant mice.
Intrahippocampal infusion of AAV-GFP-p75 in HdhQ7/Q7 WT mice 
reproduces HD memory deficits. To further evaluate whether the 
aberrant increase in hippocampal p75NTR levels could contribute to 
memory impairments in HD mutant mice, we next tested whether 
overexpression of p75NTR only in the hippocampus of WT mice was 
able to mimic HD memory deficits. First, we analyzed whether 
the virus serotype AAV2/8, used to overexpress p75NTR, was able 
to infect glia and/or neuronal cells (Supplemental Figure 6B). 
Fluorescence microscopy analysis demonstrated that AAV2/8 
efficiently transduces hippocampal neurons but not astrocytes, 
indicating that the 2/8 serotype is greatly specific for neurons. 
Then, AAV2/8 serotype specificity was tested in vivo. Slices from 
WT animals injected with AAV2/8-p75NTR viruses were stained 
with antibodies against GFAP, and colocalization with GFP was 
analyzed by confocal microscopy (Supplemental Figure 6C). 
Consistent with our in vitro data, no overlap in staining between 
GFAP and GFP was found, indicating that AAV2/8 viruses primar-
Figure 8. Intrahippocampal infusion of AAV-GFP-p75 in WT mice recapitulates the cognitive deficits 
observed in KI mice. (A) Western blot for p75NTR and actin as loading control in total hippocampus extracts 
from AAV-GFP– (AAV-ctl–) and AAV-p75–transduced WT mice. A significant increase in p75NTR levels was 
found in AAV-p75 mice. Histogram represents mean ± SEM (n = 8 per genotype at 6 months of age). Student’s 
2-tailed t test was performed. §§P < 0.01 compared with AAV-ctl mice. (B) Percentage of time spent in arms 
(old versus novel) from AAV-ctl and AAV-p75 mice at 6 months of age (n = 8–12 per genotype). AAV-p75 mice 
exhibit no preference for a previously unexposed (novel) arm of a T-maze. (n = 8 per genotype.) Student’s 
2-tailed t test was performed. ***P < 0.001 compared with old arm. (C) Percentage of nose pokes to the new 
object from AAV-ctl and AAV-p75 mice at 6 months of age in the novel object recognition task (n = 8 per geno-
type). AAV-p75 mice display no preference for the novel object. Student’s 2-tailed t test was performed.  
§§P < 0.01 compared with AAV-ctl mice. (D) Latency to step-through from light to dark compartment from 
AAV-ctl and AAV-p75 at 6 months of age (n = 8 per genotype). AAV-p75 mice exhibit worse (shorter latency 
to crossover) retention performance than AAV-ctl mice. Student’s 2-tailed t test was performed. §§§P < 0.001 
compared with AAV-ctl mice. All histograms represent mean ± SEM.
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duced mice (Figure 10C). Importantly, by blocking of RhoA activ-
ity, the reduction of PSD95-positive clusters was prevented. These 
experiments suggest that the pathological increase of p75NTR in the 
hippocampus of HD mice leads to aberrant RhoA activity and con-
sequently dendritic spine alterations.
Discussion
In the present study we identify p75NTR as an essential contributor 
to synaptic dysfunction and memory decline in HD and extend pre-
vious studies pointing to p75NTR as a negative modulator of hippo-
campal function (23, 24, 61). We demonstrate an inverse correlation 
between p75NTR expression in the hippocampus of mutant HD mice 
and synaptic function manifested as reduced dendritic spine num-
ber, altered dendritic morphology, impaired LTP, and memory defi-
cits. In accordance, genetic normalization of p75NTR in HD knock-in 
mutant mice rescues synaptic morphology, plasticity, and memory 
deficits, likely by normalization of GTPase RhoA activity. Moreover, 
overexpression of p75NTR in the hippocampus of WT mice reproduces 
HD-like memory deficits, while specific hippocampal p75NTR knock-
down in HD mutant mice prevents such cognitive impairments.
Decades of research have long established that cognitive func-
tion declines in the premanifest and early stages of HD (62–64). 
Although several studies point to the contribution of other brain 
structures such as the hippocampus to learning and memory defi-
with our hypothesis, KI mutant mice showed a significant increase 
in hippocampal RhoA activity compared with either WT, p75+/–, 
or KI:p75+/– mice (Figure 10A). Next, we tested whether p75NTR-
mediated RhoA activation could be responsible for hippocampal 
dendritic spine pathology in HD mice. To this aim, we analyzed 
whether exogenous overexpression of p75NTR was associated with 
increased RhoA activity and whether this increase caused dendrit-
ic spine alterations. Notably, we found that RhoA activity in the 
hippocampus of WT mice overexpressing p75NTR was significantly 
higher (twofold increase) than that in control mice (Figure 10B). 
Accordingly, the analysis of hippocampal GFP-labeled dendritic 
spines revealed a significant reduction (~50%) in dendritic spine 
density in AAV-p75 mice compared with AAV-GFP mice (Figure 
10C). We verified that the reduction in spines was not merely due 
to a decrease in GFP-p75NTR staining by labeling hippocampal 
slices with an anti-phalloidin antibody (Supplemental Figure 5). 
Finally, to further validate the role of RhoA in p75NTR-induced den-
dritic abnormalities, we overexpressed p75NTR in hippocampal pri-
mary cultures, and dendritic spine-like structures were analyzed 
in the presence of the RhoA inhibitor C3 transferase. A significant 
reduction (~20%; Figure 10D) in the number of spine-like struc-
tures counted as PSD95-positive clusters (31) was found in AAV-
p75 hippocampal neurons, which agrees with our previous data 
showing a decrease in dendritic spine density in AAV-p75–trans-
Figure 9. Intrahippocampal infusion of AAV-shp75 in KI mice at 6 months restores spatial, recognition, and associative memories. (A) Western blot 
showing a significant reduction in p75NTR levels in total hippocampus extracts from AAV-shp75–injected KI mice (n = 8 per genotype). **P < 0.01 compared 
with WT mice, #P < 0.05 compared with AAV-ctl mice. (B) Percentage of time spent in arms from AAV-ctl and AAV-shp75 mice (n = 8–12 per genotype). 
AAV-shp75 mice exhibit preference for a previously unexposed arm of a T-maze. (n = 8 per genotype.) #P < 0.05 compared with AAV-ctl mice. (C) Percentage 
of time exploring the new object location (A2) from AAV-ctl and AAV-shp75 mice in the novel-object location task (n = 7–8 per genotype). AAV-shp75 mice 
showed significantly greater preference for the novel-object location. ##P < 0.01 compared with AAV-ctl mice, *P < 0.05 compared with familiar object loca-
tion. (D) Percentage of nose pokes to the new object from AAV-ctl and AAV-shp75 mice in the NORT (n = 8 per genotype). AAV-shp75 mice display preference 
for the novel object. ##P < 0.01 compared with AAV-ctl mice. (E) Latency to step-through from light to dark compartment from AAV-ctl and AAV-shp75  
(n = 8 per genotype). AAV-shp75 mice exhibit more latency to crossover than AAV-ctl. #P < 0.05 compared with AAV-ctl mice. All histograms represent  
mean ± SEM. Student’s 2-tailed t test was performed in A, D, and E and 1-way ANOVA with Bonferroni post hoc comparisons was performed in B and C.
The Journal of Clinical Investigation   R e s e a R c h  a R t i c l e
4 4 2 1jci.org   Volume 124   Number 10   October 2014
known to be critical (66–68), there is no consensus about which 
brain regions are the most important for nonspatial memory. 
Then, our behavioral data in HD mice do not completely rule out 
the contribution of other areas of the limbic system or the prefron-
tal cortex in such memory impairments.
To get insights into the molecular mechanisms contributing to 
this memory decline, we focused on p75NTR. The role of p75NTR in 
the adult brain has been mainly associated with apoptosis, whereas 
its involvement in synaptic plasticity and memory is poorly under-
stood. Null p75NTR mice exhibit enhanced LTP (21) and impaired 
LTD (23), while both null and heterozygous p75NTR mice display 
improved spatial memory (21, 22, 69). In contrast, overexpression 
cits in HD (7–9, 62, 63, 65), data from clinical trials are far from 
being conclusive on the role of the hippocampus in HD memory 
deficits. To shed new light on the contribution of the hippocampal 
circuitry to synaptic and memory decline in HD, we have evalu-
ated spatial and nonspatial memories in a precise genetic mouse 
model of HD that expresses endogenous levels of mutant hunting-
tin, HdhQ7/Q111 mice (30), by using a battery of different behavioral 
tests. We demonstrated impairments in spatial, recognition, and 
associative memories in HdhQ7/Q111 mutant mice at early and mild 
disease stages, suggesting hippocampal dysfunction in our HD 
mouse models. However, we would like to emphasize that even 
though the contribution of the hippocampus in spatial tasks is 
Figure 10. Increased RhoA activity contributes to p75NTR-mediated dendritic spine loss in mutant KI mice. (A) Hippocampal lysates from WT, KI, p75+/–, 
and KI:p75+/– mice at 6 months of age were subjected to RhoA activity assays. Quantification of the RhoA-GTP levels adjusted to the total RhoA is shown. 
One-way ANOVA with Tukey post hoc comparisons was performed; n = 5 animals per genotype. **P < 0.01 compared with WT mice. (B) Hippocampal 
lysates from AAV-ctl– and AAV-p75–transduced WT mice were subjected to RhoA activity. Quantification of the RhoA-GTP levels adjusted to the total 
RhoA is shown. Student’s 2-tailed t test was performed; n = 5–6 per genotype. §§§P < 0.001 compared with AAV-ctl mice. (C) Left: Quantitative analysis 
showing dendritic spine density. AAV-p75 mice exhibit a significant reduction in dendritic spines compared with AAV-ctl mice. Student’s 2-tailed t test 
was performed; 32 dendrites (AAV-ctl) and 26 dendrites (AAV-p75) from 3 animals per condition were analyzed. §§§P < 0.001 compared with AAV-ctl mice. 
Right: Representative confocal microscopy images of CA1 dendrites from AAV-ctl and AAV-p75 mice. Arrowheads indicate dendritic spines. (D) Hippocam-
pal neurons were transduced at DIV14 with AAV-ctl or AAV-p75 and at DIV20 treated with the RhoA inhibitor C3 transferase. Left: Quantitative analysis 
showing the density of PSD95 clusters. Two-way ANOVA comparing groups × treatment with Bonferroni post hoc comparisons was performed. §§§P < 0.001 
compared with control AAV-ctl–treated neurons. Right: Representative confocal microscopy images showing PSD95 clusters (red) in GFP-labeled neurons. 
All histograms represent mean ± SEM.
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that the transcription factor Sp1 drives the expression of p75NTR 
upon neuronal injury or distinct stress inducers (32, 33). Moreover, 
Sp1 has been described to be increased in cellular and transgenic 
models of HD (34). In accordance with these findings, we found a 
significant increase in Sp1 protein levels in the hippocampus of HD 
mice and HD human brain, supporting the idea that deregulation 
of Sp1 activity by mutant huntingtin could underlie the increase 
in p75NTR mRNA observed in HD hippocampus. However, we can-
not rule out that other transcription factors known to regulate 
p75NTR expression might also contribute to p75NTR deregulation. 
For instance, it was recently shown that p75NTR is a direct transcrip-
tional target of the transcriptional activator p73 (Tap73) (71), which 
has also been demonstrated to be hyperactive in HD mouse mod-
els and to play a relevant role in HD pathology (72). Interestingly, 
hippocampal p75NTR and Tap73 expression is increased in AD (73, 
74), suggesting that the p73/p75NTR axis may also play an important 
role in the pathology of neurodegenerative diseases (71).
Several mechanisms can explain how aberrant p75NTR levels 
mediate synaptic and memory deficits in HD. First, our results 
indicate that p75NTR directly or indirectly regulates different syn-
aptic-related proteins previously implicated in HD synaptic and/or 
cognitive deficits, such as CBP, GluA1, CaMKII, or BDNF (14, 15, 
54, 55). Indeed, memory improvements in double-mutant KI:p75+/– 
mice correlated with a recovery of the expression and/or phos-
phorylation of these molecules, leading us to propose p75NTR as a 
potential regulator of these pathways in HD synaptic pathology. 
In fact, altered expression of AMPA receptor subunits is observed 
in the hippocampus of p75NTR knockout mice (61). Second, p75NTR 
acts as a negative regulator of dendritic spine density and morphol-
ogy (24, 75). Accordingly, KI mutant mice show a significant loss 
of dendritic spines in CA1 pyramidal neurons, a phenotype recov-
ered by normalization of p75NTR levels, suggesting that synaptic and 
memory deficits in HD could be related to a reduction in the num-
ber and complexity of hippocampal dendritic spines. Interestingly, 
spine loss in HD mice is specific to thin spines, and the remaining 
ones exhibit shorter neck lengths than the thin spines found in the 
other 3 genotypes. It has been suggested that spine necks regulate 
biochemical and electrical signals through compartmentalization 
of Ca2+ and diffusion of synaptic-related proteins, which could 
modulate synapse strength (53, 76, 77). Therefore, changes in neck 
lengths together with altered number and proportion of dendritic 
spines could mediate the reduced synaptic plasticity observed in KI 
mice. It is noteworthy that despite the fact that p75+/– and KI:p75+/– 
mice do not exhibit a significant reduction in the total number of 
dendritic spines, there was a significant decrease in the proportion 
of thin spines accompanied by a significant increase in the propor-
tion of mushroom spines, thought to be highly stable with larger 
postsynaptic densities and to be the locus of long-term memories 
(78, 79). Actually, an increase in the number of mushroom spines 
might represent a homeostatic mechanism to compensate for the 
reduction of thin/learning spines (80, 81). These data suggest that 
adequate p75NTR levels are required for normal forms of synaptic 
structural plasticity and cognitive processes and that any aberrant 
p75NTR expression can be deleterious. We hypothesize that altered 
p75NTR expression above or beyond an optimal level will be critical 
for hippocampal function. Thus, levels beyond this threshold will 
not be sufficient to activate certain transduction pathways impor-
of p75NTR negatively modulates dendritic complexity and spine 
density in hippocampal neurons (24). In this scenario, we show 
that p75NTR is upregulated in the hippocampus but not in the cortex 
of HD mice and HD human brain, extending our previous studies 
showing upregulation of p75NTR in the HD striatum (30). In view of 
these data we wondered whether normalization of p75NTR levels in 
KI mice would recover HD memory deficits. In agreement with our 
hypothesis and supporting a role of aberrant hippocampal p75NTR 
expression in HD memory impairments, new double-mutant 
mice expressing mutant huntingtin but “normal” p75NTR levels 
(KI:p75+/– mice) showed preserved spatial, recognition, and asso-
ciative memories. Moreover, and according with memory decline, 
our electrophysiological studies also revealed severe hippocampal 
LTP deficiencies in HD knock-in mutant mice, in agreement with 
previous studies showing significant LTP reduction in distinct HD 
mouse models (14, 70). Importantly, normalization of p75NTR levels 
in KI:p75+/– mice restored induction and maintenance of LTP, fur-
ther supporting a critical role for p75NTR in synaptic deficits in HD.
Our data, however, do not directly support the hypothesis that 
the increase of p75NTR in the hippocampus of HD mice is respon-
sible for synaptic and memory dysfunction. One could argue that 
downregulation of p75NTR expression in other brain areas in these 
double-mutant mice could also contribute to the amelioration of 
HD memory decline. In fact, the striatal p75NTR upregulation previ-
ously reported in HD mice (30, 57) raises the question of whether 
normalization of striatal p75NTR would affect the activity of the cor-
ticostriatal circuitries by preventing or improving memory impair-
ments. To answer this question, corticostriatal pathology was also 
evaluated in KI:p75+/– mutant mice. Interestingly, normalization 
of striatal p75NTR levels in KI mice did not prevent motor learning 
deficits or corticostriatal LTP abnormalities, although a recovery of 
DARPP-32 levels was found. These data suggest that prevention of 
memory deficits in KI:p75+/– mice is associated with the normaliza-
tion of p75NTR expression in the hippocampus of KI mice, pointing 
to p75NTR as a key contributor of synaptic and memory decline in 
our HD mice. This conclusion is further supported by our findings 
on overexpression of p75NTR in the hippocampus of WT mice and 
the selective knocking down of p75NTR in the HD mouse hippocam-
pus. Notably, we found that (a) by increasing p75NTR levels only in 
the hippocampus of WT mice, it was possible to reproduce those 
memory deficits observed in HD mice; and (b) the specific reduc-
tion of p75NTR in the hippocampus of KI mutant mice completely 
prevented spatial, recognition, and associative memory deficits. 
Altogether, these findings suggest a negative effect of hippocampal 
p75NTR upregulation in synaptic and memory processes in HD mice. 
These data are in agreement with previous findings demonstrating 
a critical role of p75NTR in cognitive and synaptic dysfunction in AD. 
Increased p75NTR expression has been reported in the hippocampus 
of AD patients (26), while inhibition of p75NTR aberrant signaling by 
small molecules has been demonstrated to prevent memory defi-
cits and neuritic dystrophy in AD mouse models (27, 28).
Although the precise molecular pathways by which mutant 
huntingtin alters p75NTR expression in the hippocampus of HD mice 
remain unclear, our results demonstrate that increased p75NTR pro-
tein levels were accompanied by increased p75NTR transcripts. The 
mechanism of p75NTR transcriptional deregulation under disease 
conditions is poorly understood. However, it has been proposed 
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HD memory impairments, new and exciting therapeutic alterna-
tives can be opened. In this view, our data uncovering a new role 
of p75NTR in memory decline by regulation of structural and func-
tional synaptic plasticity support the possibility of treating synap-
tic and memory impairments in HD by pharmacological or genetic 
modulation of p75NTR function.
Methods
Animals. Heterozygous HdhQ7/Q111 knock-in mice (KI) (92) and p75+/– 
heterozygous mice (p75NTR/ExonIII) from the Jackson Laboratory were 
bred. KI and p75+/– were on a C57BL/6 genetic background. Only males 
from each genotype were used for all experiments. Male R6/1 trans-
genic mice (B6CBA background) expressing exon 1 of mutant hun-
tingtin with 145 repeats were used (93).
Postmortem brain tissues. Hippocampal (6 controls and 7 HD 
patients) and cortical (7 controls and 6 HD patients) brain tissues from 
patients with HD grades 3 and 4 (mean ± SEM; age 54.5 ± 6.5 years; 
post-mortem intervals of 4–17 hours) and control cases (mean ± SEM; 
age 53.5 ± 6.8 years; postmortem intervals of 4–18 hours) were sup-
plied by the Banc de Teixits Neurològics (Biobanc-HC-IDIBAPS).
Behavioral assessment. The T-maze spontaneous alternation task 
(T-SAT), novel object recognition task (NORT) (13), object location 
task (OLT) (94), and passive avoidance paradigm (38) were used to 
analyze hippocampal-dependent memory. Plus maze and light-dark 
tests (38) were used to analyze anxiety-like behaviors, while accelerat-
ing rotarod (95) was used to analyze motor learning.
T-SAT. The T-maze apparatus used was a wooden maze consist-
ing of 3 arms, 2 of them situated at 180° from each other, and the third 
representing the stem arm of the T, situated at 90° with respect to the 
other 2. All arms were 45 cm long, 8 cm wide, and enclosed by a 20-cm 
wall. The maze was thoroughly painted with waterproof gray paint. 
Light intensity was 5 lux throughout the maze. A starting area (10 cm) 
was located at the end of the stem arm and closed by a wooden guillo-
tine door. Two identical guillotine doors were placed in the entry of the 
arms situated at 180°. The maze was elevated 60 cm above the floor. In 
the training trial, 1 arm was closed (novel arm) and mice were placed 
in the stem arm of the T (home arm) and allowed to explore this arm 
and the other available arm (familiar arm) for 10 minutes, after which 
they were returned to the home cage. After 5 hours (long-term mem-
ory), mice were placed in the stem arm of the T-maze and allowed to 
freely explore all 3 arms for 5 minutes. The arm preference was deter-
mined by calculation of the time spent in each arm × 100/time spent 
in both arms (familiar and novel). Animals were tracked and recorded 
with SMART Junior software (Panlab).
OLT. The object location memory task evaluates spatial memory 
and is based on the ability of mice to recognize when a familiar object 
has been relocated. Exploration took place in an open-top arena with 
quadrangular form (45 × 45 cm). The light intensity was 40 lux through-
out the arena, and the room temperature was kept at 19°C–22°C and 
40%–60% humidity. Mice were first habituated to the arena in the 
absence of objects (2 days, 10 min/d). On the third day during the acqui-
sition phase mice were allowed to explore 2 duplicate objects (A1 and A2), 
which were placed in the far corners of the arena for 10 minutes. After a 
delay of 24 hours, 1 object was placed in the corner diagonally opposite. 
Thus, both objects in the phase were equally familiar, but 1 was in a new 
location. The position of the new object was counterbalanced between 
mice. Animals were tracked and recorded with SMART Junior software.
tant for some forms of synaptic plasticity (impaired performance 
of p75+/– mice in the passive avoidance), while levels above this opti-
mal expression, as in our HD mice, will induce overactivation of 
p75NTR signaling and deregulation of p75NTR-modulated molecular 
pathways essential for memory processes (increased RhoA activity 
and subsequent altered dendritic spines and cognition in KI mice).
Our results also suggest that the observed loss of spines found 
in mutant KI mice could be due to altered p75NTR synaptic local-
ization. p75NTR expression in the hippocampus has been classically 
restricted to afferents coming from basal forebrain cholinergic 
neurons (82–84). However, recent evidence in vivo and in vitro 
also demonstrates dendritic spine localization of p75NTR in CA1 
and dentate gyrus of hippocampal neurons (19, 23, 85, 86). In 
accordance with these studies, we found colocalization of p75NTR 
with MAP2 and PSD95 in hippocampal pyramidal neurons of 
CA1, revealing a postsynaptic localization of p75NTR. Interestingly, 
p75NTR was increased in synapses in KI mutant mice, suggesting 
that postsynaptic p75NTR could have negative effects on synaptic 
function in HD. Besides p75NTR expression in neurons, it has been 
reported that astrocytes induce p75NTR expression after different 
types of injury (36, 86, 87). Increased levels of p75NTR have been 
detected in both neurons and astrocytes in the hippocampal CA3 
region after seizures (37). However, our results showed no colo-
calization between GFAP and p75NTR in the hippocampus of KI 
mutant mice, suggesting that the increase in p75NTR levels in these 
HD mutant mice is predominantly neuronal. Accordingly, specif-
ic neuronal overexpression of p75NTR in the hippocampus of WT 
mice mimics HD-like memory deficits, further supporting the idea 
that the increase in p75NTR levels in the hippocampal neurons of 
KI mutant mice is responsible, at least partially, for the synaptic 
plasticity and memory impairments in HD mice.
How might increased p75NTR levels lead to dendritic spine 
changes? We built on work showing that p75NTR receptor modulates 
the activity of RhoA, a Rho family of small GTPases important for 
the maintenance of the dendritic spines (59, 88). RhoA has com-
plex effects on spines. While sustained elevation of RhoA impairs 
maturation and maintenance of dendritic spines and reduces den-
dritic tree and neck length, brief RhoA activation after neuronal 
activity promotes actin reorganization needed for LTP consolida-
tion (60, 89, 90). Given that p75NTR acts as a constitutive RhoA 
activator (25, 91), we speculate that prolonged RhoA stimulation 
due to high p75NTR levels in the hippocampus of KI mutant mice 
could destabilize actin spine cytoskeleton and compromise the 
integrity of spines. In this context, we found increased RhoA acti-
vation in the hippocampus of mutant KI but not in double-mutant 
KI:p75+/– mice compared with WT mice, suggesting a direct link 
between p75NTR-induced dendritic loss and aberrant RhoA activ-
ity. In favor of this hypothesis, we found recovery of PSD95-posi-
tive clusters in AAV-p75–transduced hippocampal cultures treated 
with the RhoA inhibitor C3 transferase.
In conclusion, our findings demonstrate a detrimental role 
of hippocampal p75NTR upregulation in synaptic and memory 
function in HD. These results, along with previous studies in HD 
mouse and monkey models reporting hippocampal pathology, 
underline the need to address the pathogenic significance of the 
hippocampus in memory and synaptic decline in HD patients. By 
working on the hypothesis that the hippocampus can play a role in 
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of 5 minutes. The time latency was recorded when the animal was 
unable to keep up with the increasing speed and fell. Rotarod training 
and testing was performed 4 times per day during 3 consecutive days.
Viral constructs and stereotaxic injection. For p75NTR overexpres-
sion the plasmid pEGFP-N3-p75 obtained from E. Formaggio (Depart-
ment of Medicine and Public Health, Pharmacology Section, Univer-
sity of Verona, Verona, Italy) was used to clone into a rAAV2/8-GFP 
adenoviral vector (BamHI site at 5′ and AgeI at 3′). For knockdown 
p75NTR expression we designed a siRNA oligomer targeting the mouse 
p75NTR:Ngfr-1 to clone into a rAAV2/8-GFP adenoviral vector as previ-
ously described. Infectious AAV viral particles containing GFP expres-
sion cassette with scrambled shRNA (AAV-ctl), shRNAp75 (AAV-
shp75), GFP (AAV-GFP), or p75NTR expression cassette (AAV-p75) were 
generated by the Unitat de Producció de Vectors from the Center of 
Animal Biotechnology and Gene Therapy at the Universitat Autònoma 
de Barcelona. Following anesthesia with pentobarbital (30 mg/kg), 
5-month-old mice were injected with AAV-GFP, AAV-p75, and AAV-
shp75 (viral concentration ranging from 1.53 × 109 to 3.06 × 109 GCs per 
injection, n = 8 per group) at 2 sites of the hippocampus according to the 
following coordinates from the bregma (millimeters); anteroposterior, 
–1.6 and –1.9; lateral, +2.0 and +3.0; and dorsoventral, –0.8 and –1.2. 
AAVs were injected over 2 minutes, leaving the cannula in place for 5 
additional minutes to ensure complete diffusion of the viruses, and 
then slowly retracted from the brain. The animals were monitored for 
2 hours after administration and then returned to the housing facility 
for 30 days. After this period, animals from experimental groups were 
subjected to behavioral assessment.
Total protein extraction and subcellular fractionation. Total protein 
extraction was performed as described elsewhere (30). For cytosolic and 
nuclear fractions, tissue was homogenized in lysis buffer (4 mM HEPES, 
0.32 M sucrose, 2 mM PMSF, 10 mg/ml aprotinin, 1 mg/ml leupeptin, 
2 mM Na3VO4, and 0.1 mg/ml benzamidine) with a Teflon-glass potter 
and centrifuged at 800 g for 10 minutes to obtain the cytosolic (super-
natant) and the nuclear (pellet) fractions. The pellet was resuspended 
in lysis buffer and centrifuged at 800 g for 10 minutes. The resulting 
pellet, containing washed nuclear fraction, was then resuspended in 
lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10% glycerol, 1% 
Triton X-100, 5 mM ZnCl2, 10 mM EGTA, 2 mM PMSF, 10 mg/ml apro-
tinin, 1 mg/ml leupeptin, 0.1 mg/ml benzamidine, 2 mM Na3VO4, and 
100 mM NaF) and incubated for 30 minutes at 4°C in a tube rotator. 
Finally, after centrifugation for 20 minutes at 15,700 g, the supernatant 
was collected and stored at −80°C until use. Protein concentration was 
measured using the DC protein assay kit (Bio-Rad).
Western blotting. Western blot experiments were performed 
as previously described (15, 29). Antibodies used for Western blot 
analysis were anti-p75NTR (1:1,000; Promega); anti-CaMKII, anti–
phospho-CaMKIIThr286, anti-BDNF, and anti-CBP (1:1,000; Santa 
Cruz Biotechnology); anti-GluA1 and anti-GluA2/3 (1:1,000; Upstate 
Biotechnology); anti–phospho-GluA1Ser831 (1:1,000; Millipore); anti-
actin (1:10,000; MP Biochemicals); anti-PSD95 (1:2,000; Affinity 
Bioreagents); anti-PSD93 (1:1,000; Alomone); anti-SAP102 (1:1,000; 
Synaptic Systems); anti-spinophilin (1:1,000; Upstate Biotechnology); 
anti-GluN2B (1:1,000; Chemicon); anti-GluN1 (1:1,000; Chemi-
con); anti-synaptophysin (1:1,000; Abcam); anti-RhoA (1:1,000; Cell 
Signaling); anti-SP1 (1:500; Santa Cruz Biotechnology); anti-NeuN 
(1:1,000; Millipore); anti-DARPP-32 (1:1,000; BD Bioscience); and 
anti–α-tubulin (1:20,000; Sigma-Aldrich).
NORT. The device consisted of a white circular arena with 40 cm 
diameter and 40 cm high. The light intensity was 40 lux through-
out the arena, and the room temperature was kept at 19°C–22°C and 
40%–60% humidity. Mice were first habituated to the arena in the 
absence of objects (2 days, 10 min/d). On the third day, 2 similar 
objects were presented to each mouse during 10 minutes (A1 and A2 
condition), after which they were returned to their home cage. Twenty- 
four hours later (long-term memory), the same animals were retested 
for 5 minutes in the arena with a familiar and a new object (A2 and B 
condition). The object preference was measured as the time exploring 
each object × 100/time exploring both objects. The arena was rigor-
ously cleaned between animal trials in order to avoid odors. Animals 
were tracked and recorded with SMART Junior software.
Passive avoidance. The passive avoidance (light-dark) paradigm was 
performed as described elsewhere (96, 97) with slight modifications. 
Experiments are conducted in a 2-compartment box, where 1 com-
partment is dimly lit (20 lux) and preferable to a rodent, and the other 
compartment is brightly lit (200 lux); both chambers are connected by 
a door (5 cm × 5 cm). During training, mice were placed into the aversive 
brightly lit compartment, and upon the entry into the preferred dimly 
lit compartment (with all 4 paws inside the dark chamber), mice were 
exposed to a mild foot shock (2-second foot shock, 1 mA intensity). The 
latency of mice to enter into the dark chamber was recorded. Twenty 
seconds after receiving the foot shock, mice were returned to the home 
cage until testing. After 24 hours (long-term memory) the animal under-
goes a retention test (testing). In the retention test, mice were returned 
to the brightly lit compartment again, and the latency to enter the shock-
paired compartment (dark chamber) was measured (retention or recall 
latency). Ten minutes was used as a time cutoff in the retention test. The 
animal that learned the task would avoid the location previously paired 
with the aversive stimulus, and would show greater latency to enter it.
Plus maze. To analyze mouse anxiety-like behaviors, the plus 
maze paradigm was performed as previously described (38). Briefly, 
the raised plus maze was made of wood and consisted of 2 opposing 
open arms of 30 × 8 cm, and 2 opposing arms of 30 × 8 cm enclosed 
by 15-cm-high walls. The maze was raised 50 cm from the floor and 
lit by dim light. Each mouse was placed in the central square of the 
raised plus maze, facing an open arm, and the behavior was scored for 
5 minutes. At the end of each trial, any feces were removed and the 
apparatus was wiped with 70% alcohol. We recorded the time spent in 
the open arms, which normally correlates with levels of anxiety. Ani-
mals were tracked and recorded with SMART Junior software.
Light-dark paradigm. The light-dark paradigm was performed as 
described elsewhere (98) with slight modifications. The light-dark box 
consisted of 2 compartments, which were connected by a door (5 cm × 
5 cm) located at floor level in the center of the partition. The light com-
partment was white and directly illuminated by a dim light (200 lux), 
while the dark compartment was black and completely enclosed (20 
lux). The test was performed in a dimly lighted room. Each animal was 
initially confined in the dark compartment and allowed to freely explore 
the apparatus for 5 minutes. The parameters recorded were time spent 
by each mouse in the light compartment and latency time for the first 
crossing to the light compartment. Between animals, the apparatus was 
carefully cleaned with 70% ethanol solution and allowed to dry.
Accelerating rotarod training procedure. As previously described 
(99), animals were placed on a motorized rod (30 mm diameter). The 
rotation speed gradually increased from 4 to 40 rpm over the course 
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supplement (Gibco-BRL) and 500 ml of GlutaMAX (100×) (Gibco-
BRL) was used to grow the cells in serum-free medium conditions 
and maintained at 37°C in 5% CO2. Two weeks after plating (DIV14), 
neurons were transduced with AAV-GFP or AAV-p75 (40,000 GCs 
per cell) in Neurobasal maintenance medium for up to 1 week. At 
DIV20, cells were treated with vehicle or C3 ADP ribosyl transferase, 
a cell-permeable Rho inhibitor (100 ng/ml; Cytoskeleton Inc.), for 
24 hours. At DIV21, neurons were fixed for 10 minutes in 4% PFA for 
immunostaining and confocal analysis.
Immunocytochemistry and image analysis. Fixed cultures were per-
meabilized for 10 minutes at room temperature with 0.5% saponin in 
PBS and blocked with 15% horse serum in PBS. The cells were incubat-
ed with anti-PSD95 (1:1,000; Affinity Bioreagents) and secondary anti-
bodies (Cy3, 1:200; Jackson ImmunoResearch). Single images were 
acquired digitally using Leica Confocal SP5 with a ×63 oil-immersion 
objective and a digital zoom of 3. Conditions such as pinhole size (1 AU) 
and frame averaging (4 frames per z-step) were held constant through-
out the study. PSD95 clusters in dendrites from GFP-labeled neurons 
were quantified using the freeware NIH ImageJ version 1.33 by Wayne 
Rasband (NIH). At least 60 neurites (1–2 neurites per neuron) for each 
condition in 3 independent experiments were analyzed.
Immunofluorescence and SL confocal analysis. Immunofluorescence 
experiments and analysis were carried out as previously described 
(30, 101). Antibodies against p75NTR (1:100; Promega), GFP (1:1,000; 
Upstate Biotechnology), PSD95 (1:1,000; Affinity Bioreagents), and 
MAP2 (1:500; Sigma-Aldrich) and secondary antibodies (Alexa Fluor 
488 and 555, Jackson ImmunoResearch) were used. Stained coronal 
sections were examined blinded to genotype by confocal microscopy, 
using a Leica TCS SL laser scanning confocal spectral microscope 
with argon and helium-neon lasers. Images were taken with a 63× 
numerical aperture lens with 4× digital zoom and standard (1 Airy 
disc) pinhole. For each mouse, at least 3 slices of 30 μm containing hip-
pocampal tissue were analyzed. Up to 3 representative images, from 
CA1-stratum radiatum layer, were obtained from each slice. For each 
image, the entire 3D stack of images was obtained by the use of the 
Z drive present in the Leica TCS SL microscope, and the size of the 
optical image was 0.5 μm, with a separation of 2 μm between each. The 
number of double-labeled p75NTR/PSD95-positive clusters was count-
ed by the freeware NIH ImageJ version 1.33 by Wayne Rasband (NIH).
Dendritic spine dying and SP5 confocal analysis. Neurons were labeled 
using the Helios Gene Gun System (Bio-Rad) as previously described 
(102, 103). Briefly, a suspension containing 3 mg of DiI (Molecular 
Probes, Invitrogen) dissolved in 100 μl of methylene chloride (Sigma-
Aldrich) and mixed with 50 mg of tungsten particles (1.7 mm diameter; 
Bio-Rad) was spread on a glass slide and air-dried. The mixture was 
resuspended in 3.5 ml distilled water and sonicated. Subsequently, the 
mixture was drawn into Tefzel tubing (Bio-Rad), and then removed to 
allow tube drying during 5 minutes under a nitrogen flow gas. Then, 
the tube was cut into 13-mm pieces to be used as gene gun cartridges. 
Dye-coated particles were delivered in the hippocampus using the fol-
lowing protocol. Shooting was performed over 200-μm coronal sections 
at 80 psi through a membrane filter of 3 μm pore size and 8 × 10 pores/
cm2 (Millipore). Sections were stored at room temperature in PBS for 
3 hours protected from light and then incubated with DAPI, and mount-
ed in Mowiol to be analyzed. DiI-labeled pyramidal neurons from CA1 
of the dorsal hippocampus were imaged using a Leica Confocal SP5 
with a ×63 oil-immersion objective. Conditions such as pinhole size 
RhoA pull-down assay. The Rho-GTP pull-down assay was per-
formed using a RhoA activation assay kit according to manufacturer 
instructions (Cell Biolabs). Hippocampal tissue was homogenized in 
ice-cold 1× assay/lysis buffer. Samples were centrifuged at 14,000 g 
for 10 minutes at 4°C, and the supernatant (1 mg of protein) was incu-
bated with Rhotekin RBD-agarose beads at 4°C for 1 hour on a rotator. 
The beads were washed 3 times with 0.5 ml of 1× assay buffer. Protein 
samples were eluted with 1× SDS-PAGE sample buffer and processed 
for Western blotting using RhoA antibody.
Real-time quantitative RT-PCR. Total RNA was isolated from the 
hippocampus and cortex of HD mutant and WT mice using the Total 
RNA Isolation Nucleospin RNA II Kit (Macherey-Nagel). Purified RNA 
(500 ng) was reverse transcribed using the PrimeScript RT Reagent Kit 
(Perfect Real Time, Takara Biotechnology Inc.). The cDNA synthesis 
was performed at 37°C for 15 minutes and a final step at 85°C for 5 sec-
onds in a final volume of 20 μl according to the manufacturer’s instruc-
tions. The cDNA was then analyzed by quantitative RT-PCR using the 
following TaqMan Gene Expression Assays (Applied Biosystems): 18S 
(Hs99999901_s1) and p75NTR (Mm00446294_m1). RT-PCR was per-
formed in 12.5 μl of final volume on 96-well plates using the Premix 
Ex Taq. Reactions included 40 cycles of a 2-step PCR: 95°C for 5 sec-
onds and 60°C for 20 seconds, after initial denaturation at 95°C for 
30 seconds. All quantitative PCR assays were performed in duplicate. 
To provide negative controls and exclude contamination by genomic 
DNA, the RT was omitted in the cDNA synthesis step. The quantitative 
PCR data were quantified using the comparative quantitation analysis 
program of MxProTM quantitative PCR analysis software version 3.0 
(Stratagene) with the 18S gene expression as loading control.
Histology and stereology. Hippocampal volume estimations were 
performed following the Cavalieri method. The number of Nissl-
positive neurons in the CA1 pyramidal cell layer was established using 
unbiased design-based stereology blinded to genotype and group and 
was performed using Computer-Assisted Stereology Toolbox (CAST) 
software (Olympus Danmark A/S). Specifically, we used the dissec-
tor counting procedure in 12 hippocampal coronal sections (30 μm 
thick) per animal, spaced 240 μm and covering the entire rostrocaudal 
extent of this brain region.
Primary culture of astrocytes. Primary astrocyte cultures were 
obtained from P1 to P3 WT mouse pups by cortical dissection and 
removal of the meninges. Extracted tissue was mechanically disso-
ciated and resuspended in MEM 1× conditioned media NM-15 (20% 
FBS, Gibco-BRL; 90 mM d-glucose, Sigma-Aldrich) with l-glutamine 
and Earle’s salts (Gibco-BRL), plated in 25-cm2 flasks, and cultured at 
37°C with 5% CO2. After 2 passages, cultures were purified by shaker 
agitation during 10 minutes at 400 rpm, and undesired floating cells 
were discarded. Medium was replaced and seeded astrocytes main-
tained 2 hours at 37°C in agitation for 16–18 hours at 250 rpm, floating 
cells removed, and new medium replaced. Twenty-four hours later, 
astrocytes were trypsinized, seeded at 1 × 106 cells in P100 plates, and 
allowed to reach 100% confluence. Astrocytes were transduced with 
AAV-GFP or AAV-p75 (40,000 GCs per cell).
Primary culture of mouse hippocampal neurons and adenovirus-
mediated gene transduction. Primary hippocampal neurons were 
prepared from E18.5 mouse embryos as previously described (100). 
The neuronal cell suspension was seeded (70,000 cells/cm2) on cov-
erslips precoated with poly-d-lysine (0.1 mg/ml; Sigma-Aldrich) in 
24-well plates. Neurobasal medium containing 1 ml of 1× B27 (50) 
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spaced 10 seconds, and potentiation was measured for 1 hour after LTP 
induction at 0.1 Hz. For each experiment, population spike (PS) ampli-
tude was expressed as a percentage of average pre-tetanus baseline 
amplitude. Data were stored on a Pentium-based PC using a PowerLab 
4/26 acquisition system (AD Instruments); Scope software (AD Instru-
ments) was used to display PS and measurements of the amplitude of 
PSs. Statistical differences, compared with pre-tetanus baseline ampli-
tude values, were established using the 2-tailed Student’s t test.
Statistics. All data are expressed as mean ± SEM. Statistical analy-
sis was performed using the unpaired Student’s t test (2-tailed, 95% 
confidence), the Kolmogorov-Smirnov test to compare cumulative 
distributions, 1-way ANOVA, 2-way ANOVA, and the appropriate post 
hoc tests as indicated in the figure legends. Values of P < 0.05 were 
considered statistically significant.
Study approval. Human samples were provided by Banc de Teixits 
Neurològics (Biobanc-HC-IDIBAPS). The Banc de Teixits Neurològics 
was established to provide human postmortem brains to researchers 
in Spain, taking into consideration all the ethical guidelines of the lat-
est Declaration of Helsinki. Informed consent was obtained from all 
subjects under study. Experimental animal procedures were approved 
by the Local Ethical Committee of the University of Barcelona (99/01) 
and the Generalitat de Catalunya (00/1094), following European 
(2010/63/UE) and Spanish (RD 1201/2005) regulations for the care 
and use of laboratory animals.
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(1 AU) and frame averaging (4 frames per z-step) were held constant 
throughout the study. Confocal z-stacks were taken with a digital zoom 
of 5, a z-step of 0.2 μm, and at 1,024 × 1,024 pixel resolution, yielding an 
image with pixel dimensions of 49.25 × 49.25 μm. Z-stacks were decon-
volved using the Acoloma plug-ins from ImageJ, to improve voxel reso-
lution and reduce optical aberration along the z-axis. Segments of basal 
dendrites and proximal apical dendrites were selected for the analysis of 
spine density and spine morphology according to the following criteria: 
(a) segments with no overlap with other branches that would obscure 
visualization of spines and (b) segments either “parallel” to or “at acute 
angles” relative to the coronal surface of the section to avoid ambigu-
ous identification of spines. Only spines arising from the lateral surfaces 
of the dendrites were included in the study; spines located on the top 
or bottom of the dendrite surface were ignored. Given that spine den-
sity increases as a function of the distance from the soma, reaching a 
plateau 45 μm away from the soma, we selected dendritic segments of 
basal dendrites 45 μm away from the cell body.
For a more precise description of the dendritic shape changes, the 
spine head diameter was analyzed as a continuous distribution. To this 
end, we proceeded as follows: first all the identified spines were catego-
rized as spines without neck (stubby spines) or with a clear neck. From 
the latter, blind measurements of the head diameter were performed 
manually using ImageJ for all the spines in control mice. Then, a distri-
bution analysis of head diameter was performed. The Gaussian adjust-
ment resulted in a normal distribution with a mean value of 0.5009 μm 
(Gaussian fit P = 0.90) (Supplemental Figure 4). From the estimated 
mean value, spine populations were divided into spines with diameters 
below the mean average (head diameters <0.5009 ± 0.006 μm, thin 
spines), spines with head diameters above the mean value (head diam-
eters >0.5009 ± 0.006 μm, mushrooms), and a third category includ-
ing all the non-neck spines (stubby spines). Spine neck was measured 
as the distance from the dendritic shaft to the head of the spine.
Electrophysiology. Coronal brain slices (400 μm thickness) were 
prepared from WT, p75+/–, KI, and KI:p75+/– mice (6 months old) as 
described previously (104) and incubated for more than 1 hour at room 
temperature (21°C–24°C) in ACSF (in mM: NaCl 124, KCl 2.69, KH2PO4 
1.25, MgSO4 2, NaHCO3 26, CaCl2 2, and glucose 10) and were gassed 
with 95% O2 and 5% CO2. Slices containing hippocampus or striatum 
and cortex were transferred to an immersion recording chamber and 
superfused (2.5 ml/min) with equilibrated ACSF maintained at constant 
temperature (34°C). To evaluate hippocampal LTP, extracellular field 
excitatory postsynaptic potentials (fEPSPs) were recorded with a glass 
microelectrode (impedances 2–3 MΩ; filled with 1 M NaCl) positioned 
in stratum radiatum area CA1 of the hippocampus. Evoked fEPSPs were 
elicited by stimulation of the Schaeffer collateral fibers with an extra-
cellular bipolar tungsten electrode via a 2100 isolated pulse stimulator 
(A-M Systems Inc.). LTP was induced by application of 4 trains (1 sec-
ond at 100 Hz) spaced 20 seconds, and potentiation was measured for 
1 hour after LTP induction at 0.1 Hz. Corticostriatal LTP was induced 
by application of tetanic stimulation twice (4 trains 1 second at 100 Hz) 
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